Latest Breaking News On - Ben shannon - Page 9 : comparemela.com

Tonix Pharmaceuticals Completes Clinical Phase of PREVAIL Proof-of-Concept Study of TNX-102 SL for the Treatment of Fibromyalgia-Type Long COVID

Tonix Pharmaceuticals Completes Clinical Phase of PREVAIL Proof-of-Concept Study of TNX-102 SL for the Treatment of Fibromyalgia-Type Long COVID
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

United statesSeth ledermanPeter vozzoJessica morrisHerbert harrisCalabresel annZembrace symtouchBen shannonHuman servicesUs national institutes of healthPublic health revExchange commissionCenters for diseaseNational institutes of allergyTonix pharmaceuticalsTrademark office

Ocular Therapeutix™ Provides Second Quarter 2023 Financial Results and Corporate Update

Ocular Therapeutix™ Provides Second Quarter 2023 Financial Results and Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Park cityUnited statesBen shannonDonald notmanAntony mattessichChris brinzeyOcular therapeutix incMidcap financialExchange commissionSanten incProvides second quarterNet product revenueRepresenting growthCash runway now forecastedTwo planned pivotal clinical trialsNon proliferative diabetic retinopathy

Ocular Therapeutix™ Provides Second Quarter 2023 Financial Results and Corporate Update

Ocular Therapeutix™ Provides Second Quarter 2023 Financial Results and Corporate Update
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesPark cityBen shannonChris brinzeyDonald notmanAntony mattessichSanten incMidcap financialOcular therapeutix incExchange commissionNet product revenueRepresenting growthCash runway now forecastedTwo planned pivotal clinical trialsNon proliferative diabetic retinopathyBegan pilot repeat dose

Tonix Pharmaceuticals Announces Pricing of $7 Million Public Offering

CHATHAM, N.J., July 27, 2023 Tonix Pharmaceuticals Holding Corp. , a biopharmaceutical company, today announced it has entered into a securities purchase agreement for the purchase and sale of.

New yorkUnited statesJessica morrisZembrace symtouchBen shannonPeter vozzoGlobenewswire incNeurelis incAlliance global partnersExchange commissionTonix pharmaceuticalsAegis therapeuticsArcadia securitiesTonix pharmaceuticals holding corpPharmaceuticals holdingGlobal partners

Tonix Pharmaceuticals Announces Pricing of $7 Million

CHATHAM, N.J., July 27, 2023 (GLOBE NEWSWIRE) Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical.

New yorkUnited statesZembrace symtouchJessica morrisPeter vozzoBen shannonTonix pharmaceuticals holding corpA gp alliance global partnersTonix pharmaceuticalsAegis therapeuticsArcadia securitiesExchange commissionNeurelis incPharmaceuticals holdingAlliance global partnersCapital markets